Español
India
Italiano
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
LeMaitre Vascular
LMAT
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$82.28
0
0.00%
At Close: -
$82.28
0
0.00%
After Hours: 4:19 PM EDT
15 minutes delayed
Get Report
Watch
LeMaitre Vascular (LMAT) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for LeMaitre Vascular (NASDAQ:LMAT) Stock
LeMaitre Vascular Stock (NASDAQ: LMAT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, June 26, 2024
GE HealthCare's New Tie-Up to Boost CVD Workflow
Zacks
Friday, May 31, 2024
Navigating 4 Analyst Ratings For LeMaitre Vascular
Benzinga Insights
Roth MKM Reinstates Buy on LeMaitre Vascular,...
Benzinga Newsdesk
Friday, May 03, 2024
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk
Thursday, May 02, 2024
LeMaitre Vascular Sees Q2 EPS $0.45-$0.50 vs ...
Benzinga Newsdesk
LeMaitre Vascular Q1 2024 GAAP EPS $0.44 Beat...
Benzinga Newsdesk
Friday, April 26, 2024
Stifel Upgrades LeMaitre Vascular to Buy, Rai...
Benzinga Newsdesk
Wednesday, March 27, 2024
Engaging In Options Activity, George LeMaitre Exercises Options Valued At $266K In LeMaitre Vascular
Benzinga Insights
Tuesday, March 05, 2024
Insider Transaction: George LeMaitre Sells $6.94M Worth Of LeMaitre Vascular Shares
Benzinga Insights
Strategic Sale: Joseph Pellegrino JR Decides To Exercise Options Worth $1.08M At LeMaitre Vascular
Benzinga Insights
Wednesday, February 28, 2024
Barrington Research Maintains Outperform Rating for LeMaitre Vascular: Here's What You Need To Know
Benzinga Insights
LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk
Tuesday, February 27, 2024
LeMaitre Vascular Sees Q1 EPS $0.36-$0.41 vs ...
Benzinga Newsdesk
Recap: LeMaitre Vascular Q4 Earnings
Benzinga Insights
LeMaitre Vascular Q4 2023 GAAP EPS $0.38 Beat...
Benzinga Newsdesk
Earnings Scheduled For February 27, 2024
Benzinga Insights
Monday, February 26, 2024
A Preview Of LeMaitre Vascular's Earnings
Benzinga Insights
Tuesday, February 06, 2024
Keybanc Initiates Coverage On LeMaitre Vascul...
Benzinga Newsdesk
Thursday, December 28, 2023
George LeMaitre At LeMaitre Vascular Capitalizes: Options Exercised, Resulting In $350K
Benzinga Insights
Tuesday, December 12, 2023
Chairman and CEO At LeMaitre Vascular Sells $2.79M Of Stock
Benzinga Insights
Wednesday, November 29, 2023
LeMaitre Vascular Board Member Acquires 7,500 Shares After Exercising Company Stock Options
Benzinga Insights
Wednesday, November 22, 2023
Chairman and CEO at LeMaitre Vascular Exercises Options Worth $678K
Benzinga Insights
Wednesday, November 01, 2023
LeMaitre Vascular Sees Q4 EPS $0.34-$0.38 Vs ...
Benzinga Newsdesk
LeMaitre Vascular Q3 EPS $0.33 Beats $0.30 Es...
Benzinga Newsdesk
Earnings Scheduled For November 1, 2023
Benzinga Insights
Monday, October 23, 2023
5 Analysts Have This to Say About LeMaitre Vascular
Benzinga Insights
JMP Securities Initiates Coverage On LeMaitre...
Benzinga Newsdesk
Wednesday, September 06, 2023
Why LeMaitre Vascular Is A Market Leader In Core Segments: Oppenheimer Initiates With Outperform Rating
Vandana Singh
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
Benzinga Insights
Oppenheimer Initiates Coverage On LeMaitre Va...
Benzinga Newsdesk
Thursday, August 03, 2023
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023
Benzinga Insights
Yum! Brands To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Thursday
Lisa Levin
Jefferies Downgrades LeMaitre Vascular to Hol...
Benzinga Newsdesk
Wednesday, August 02, 2023
Lake Street Maintains Buy on LeMaitre Vascula...
Benzinga Newsdesk
Barrington Research Maintains Outperform on L...
Benzinga Newsdesk
Tuesday, August 01, 2023
LeMaitre Vascular Q2 Adj EPS $0.37 Beats $0.3...
Benzinga Newsdesk
Earnings Scheduled For August 1, 2023
Benzinga Insights
Wednesday, May 24, 2023
LeMaitre Vascular Chairman and CEO Trades $444K In Company Stock
Benzinga Insights
Friday, May 19, 2023
Chairman and CEO at LeMaitre Vascular Exercises Options Worth $1.53M
Benzinga Insights
Wednesday, May 03, 2023
LeMaitre Vascular shares are trading higher a...
Benzinga Newsdesk
Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2023
Benzinga Insights
Barrington Research Upgrades LeMaitre Vascula...
Benzinga Newsdesk
Tuesday, May 02, 2023
Recap: LeMaitre Vascular Q1 Earnings
Benzinga Insights
LeMaitre Vascular Q1 EPS $0.27 Beats $0.25 Estimate, Sales $47.08M Beat $43.54M Estimate
Happy Mohamed
Thursday, April 20, 2023
LeMaitre To Become Exclusive Distributor Of Aziyo Biologics' Cardiovascular Patches
Bill Haddad
Tuesday, March 14, 2023
Lemaitre Vascular Announced That It Has Signed A Definitive Agreement To Buy Out Its Thai Distributor, Prompt Serve, For $688,000
Charles Gross
Thursday, February 23, 2023
LeMaitre Vascular Sees FY23 EPS $1.11-$1.20 Vs $1.19 Est.; FY23 Revenue $174.3M-$178.3M Vs $171.3M Est
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch